159 related articles for article (PubMed ID: 12691660)
21. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.
Staropoli JF; McDermott C; Martinat C; Schulman B; Demireva E; Abeliovich A
Neuron; 2003 Mar; 37(5):735-49. PubMed ID: 12628165
[TBL] [Abstract][Full Text] [Related]
22. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
23. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
[TBL] [Abstract][Full Text] [Related]
24. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
25. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
[TBL] [Abstract][Full Text] [Related]
26. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
27. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
28. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.
Omura T; Kaneko M; Okuma Y; Orba Y; Nagashima K; Takahashi R; Fujitani N; Matsumura S; Hata A; Kubota K; Murahashi K; Uehara T; Nomura Y
J Neurochem; 2006 Dec; 99(6):1456-69. PubMed ID: 17059562
[TBL] [Abstract][Full Text] [Related]
29. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
30. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Abbas N; Lücking CB; Ricard S; Dürr A; Bonifati V; De Michele G; Bouley S; Vaughan JR; Gasser T; Marconi R; Broussolle E; Brefel-Courbon C; Harhangi BS; Oostra BA; Fabrizio E; Böhme GA; Pradier L; Wood NW; Filla A; Meco G; Denefle P; Agid Y; Brice A
Hum Mol Genet; 1999 Apr; 8(4):567-74. PubMed ID: 10072423
[TBL] [Abstract][Full Text] [Related]
31. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
Brahmachari S; Lee S; Kim S; Yuan C; Karuppagounder SS; Ge P; Shi R; Kim EJ; Liu A; Kim D; Quintin S; Jiang H; Kumar M; Yun SP; Kam TI; Mao X; Lee Y; Swing DA; Tessarollo L; Ko HS; Dawson VL; Dawson TM
Brain; 2019 Aug; 142(8):2380-2401. PubMed ID: 31237944
[TBL] [Abstract][Full Text] [Related]
32. Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress.
Ledesma MD; Galvan C; Hellias B; Dotti C; Jensen PH
J Neurochem; 2002 Dec; 83(6):1431-40. PubMed ID: 12472897
[TBL] [Abstract][Full Text] [Related]
33. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
34. [Parkin gene and its function; a key to understand nigral degeneration].
Hattori N; Mizuno Y
Rinsho Shinkeigaku; 1999 Dec; 39(12):1259-61. PubMed ID: 10791092
[TBL] [Abstract][Full Text] [Related]
35. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
36. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.
Imai Y; Soda M; Hatakeyama S; Akagi T; Hashikawa T; Nakayama KI; Takahashi R
Mol Cell; 2002 Jul; 10(1):55-67. PubMed ID: 12150907
[TBL] [Abstract][Full Text] [Related]
37. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
38. Functional association of the parkin gene promoter with idiopathic Parkinson's disease.
West AB; Maraganore D; Crook J; Lesnick T; Lockhart PJ; Wilkes KM; Kapatos G; Hardy JA; Farrer MJ
Hum Mol Genet; 2002 Oct; 11(22):2787-92. PubMed ID: 12374768
[TBL] [Abstract][Full Text] [Related]
39. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
40. Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
Cha SH; Choi YR; Heo CH; Kang SJ; Joe EH; Jou I; Kim HM; Park SM
Mol Neurodegener; 2015 Dec; 10():63. PubMed ID: 26627850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
